Allstate Corp., US0200021014

Allstate stock gets a claims training update from Auto Lab

Published on 10/07/2026 at 16:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Allstate stock was at USD 225.05 on October 7, 2026, while Q2 revenue reached USD 18.60 billion. The next results release is set for November 4, 2026.

Aquarell-Gemälde Chicago Skyline mit Willis Tower und Spiegelung im Michigansee
Allstate Corp. US0200021014 Aquarell-Illustration der Chicagoer Skyline mit dem markanten Willis Tower am Michigansee, Illustration mit AI erstellt.

Allstate Corp. (ISIN US0200021014) was trading at USD 225.05 on the NYSE on October 7, 2026 at 10:39 a.m. ET, up 0.35 percent. The company highlighted its claims-training operation on October 6, giving investors an operational detail ahead of the next quarterly report.

Auto Lab adds claims detail

StockTitan reported that Allstate's Auto Lab includes 22 vehicles and four motorcycles, including electric, hybrid and gas-powered models. The facility is part of a 33,000-square-foot training center in Dallas that opened in August 2026.

The lab was designed using insights from more than 3.5 million auto claims, according to StockTitan. That combination of claim volume and hands-on equipment points to a practical focus on damage assessment as vehicles add sensors, cameras and electric drivetrains.

Q2 results set the baseline

Allstate's second-quarter revenue was USD 18.60 billion, up 11.8 percent from the prior-year quarter, while earnings per share reached USD 8.99 against a USD 6.06 consensus estimate, MarketBeat reported. Revenue therefore exceeded the cited estimate by USD 3.14 billion, while earnings per share exceeded consensus by USD 2.93.

The comparison matters because the next report will test whether that second-quarter gap was supported by continuing operating performance. Allstate's current claims investment is operational rather than a new earnings forecast, so its financial significance will be assessed through later loss costs, claim handling and customer outcomes.

Analysts keep target above price

MarketBeat listed 21 analyst ratings across Strong Buy, Buy, Hold and Sell categories, producing a Hold consensus and an average price target of USD 266.89. The average target lies 18.59 percent above the USD 225.05 price, a quantified gap that leaves the market focused on whether future results can support the valuation view.

November supplies the next test

Allstate Newsroom said the company will release third-quarter 2026 results after 4:15 p.m. ET on November 4, 2026, followed by the earnings call at 9:00 a.m. ET on November 5, 2026. The schedule gives investors a defined checkpoint for claims trends and the earnings profile.

Market value remains below yearly high

Allstate had a market capitalization of USD 57.9 billion as of October 7, 2026. Its 52-week range was USD 188.08 to USD 277.22, placing the USD 225.05 quote 18.83 percent below the high.

Allstate stock facts

  • Company: The Allstate Corporation
  • ISIN: US0200021014
  • Ticker: ALL
  • Trading venue: NYSE
  • Price (as of October 7, 2026, 10:39 a.m. ET): USD 225.05
  • Market capitalization: USD 57.9 billion (as of October 7, 2026)
  • 52-week range: USD 188.08-277.22 (as of October 7, 2026)
  • Sector / Industry: Financial Services / Insurance - Property and Casualty

Upcoming dates for Allstate stock

  • November 4, 2026: Third-quarter results release after 4:15 p.m. ET
  • November 5, 2026: Third-quarter earnings call at 9:00 a.m. ET

More news and analyses on Allstate stock

Disclaimer...

en | US0200021014 | ALLSTATE CORP. | boerse | 70256961 | bgmi